Yimeng Zeng, Ph.D.
About Yimeng Zeng, Ph.D.
Yimeng Zeng, Ph.D., is a Senior Scientist in Cell Therapy Technology and Platforms at Bristol Myers Squibb, with extensive experience in viral vector process development and bioreactor operations.
Title
Yimeng Zeng, Ph.D., is currently a Senior Scientist in the Cell Therapy Technology and Platforms at Bristol Myers Squibb in Seattle, Washington, United States.
Company
Yimeng Zeng, Ph.D., brings his expertise to Bristol Myers Squibb, a globally renowned pharmaceutical company. As a pivotal member of the Cell Therapy Technology and Platforms team, he contributes to significant advancements in the field. Prior to joining Bristol Myers Squibb, he worked at Lonza in Houston, Texas, where he held roles as Scientist II, Process Development, and Scientist, Research and Development.
Education and Expertise
Yimeng Zeng holds a Doctor of Philosophy (Ph.D.) in Chemical and Biomolecular Engineering from Rice University, completed in 2019. He also earned a Bachelor's degree in Pharmaceutical Engineering from Tianjin University in China. His academic background is bolstered by extensive experience in viral vector process development, bioreactor operations, and proficiency in advanced techniques like ddPCR, flow cytometry, and microscopy.
Background
Yimeng Zeng's professional journey includes significant academic and industry roles. He was a Research Assistant at Rice University's Cell and Protein Engineering Lab for seven years, where he gained profound experience in cell biology and molecular biology. He also served as a Teaching Assistant at Rice University and an Undergraduate Research Assistant at Tianjin University.
Specializations and Skills
Yimeng Zeng specializes in the Design of Experiments (DOE) and technology transfer. His skills include strong problem-solving capabilities and project management in the biotech/pharmaceutical industry. Known for his multi-tasking capabilities, he has successfully led multiple concurrent projects. His solid knowledge in chemical engineering further enhances his expertise in process development and bioassay development.